Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market. This story matters for Finance & Markets readers tracking finance. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundingWire.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily finance & markets signal